Provenance du réseau au premier degré de Dikla Berko-Ashur
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Sakura Bio
 Sakura Bio BiotechnologyHealth Technology Sakura Bio is a start-up company based in Jerusalem, Israel. Sakura Bio is developing an off-the-shelf, allogeneic T-cell therapy to fight cancer. The Israeli company's lead product, SAK-T (Super Activated Killer T-cell), is a unique T-cell population with superior anti-tumor cytotoxic activity and no toxicity of healthy tissue. The company was founded by Dikla Berko-Ashur and Amnon Peled, with Dikla Berko-Ashur serving as CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dikla Berko-Ashur via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SANDISK CORPORATION | Computer Peripherals | Corporate Officer/Principal | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree | |
M-Systems, Ltd.
 M-Systems, Ltd. Computer PeripheralsElectronic Technology msystems Ltd. develops, manufactures, and markets flash data storage solutions for the digital consumer electronics markets. Its products include mDrive and various USB-enabled devices, mDOC embedded flash drives for mobile handsets and consumer electronics devices. The company was founded in 1989 and is located in Kfar Saba, Israel. | Computer Peripherals | Corporate Officer/Principal | |
| Ben-Gurion University of the Negev | College/University | Masters Business Admin | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
Biokine Therapeutics Ltd.
 Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
| XENIA VENTURE CAPITAL LTD | Financial Conglomerates | Corporate Officer/Principal | |
PFC, Inc.
 PFC, Inc. Recreational ProductsConsumer Durables PFC, Inc. manufactures boating designs and services. The company was founded in 1979 and is headquartered in Hartsville, SC. | Recreational Products | Corporate Officer/Principal | |
Saguna Networks Ltd.
 Saguna Networks Ltd. Specialty TelecommunicationsCommunications Saguna Networks Ltd. provides mobile content delivery solutions. The firm offers Saguna Open-RAN product. It offers content optimization delivery system, a carrier grade system, providing content caching and acceleration designed to meet the demand of content over WiMAX(TM) networks. The company was founded by Lior Fite and Danny Frydman in 2008 and is headquartered in Yokneam, Israel. | Specialty Telecommunications | Director/Board Member | |
| Aniba | Chief Executive Officer | ||
| Israel Immunological Society | Director/Board Member | ||
| Solvay Business School of Economics & Management | College/University | Masters Business Admin | |
Van Leer Xenia Ventures
 Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Chief Executive Officer Chief Investment Officer | |
| VAXIL BIO LTD. | Biotechnology | Director/Board Member | |
Pyxis Diagnostics Ltd.
 Pyxis Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Pyxis Diagnostics Ltd. was founded in 2019 and is based in Jerusalem, Israel. The Israeli company's mission is to identify patients who are likely to respond to immunotherapy and to discover new targets and drug combinations to treat those who do not. The company achieves this by leveraging their ability to delineate the immune-tumor-stroma communication networks. | Miscellaneous Commercial Services | Chairman |
Statistiques
Internationale
| Israël | 12 |
| Etats-Unis | 5 |
| Belgique | 2 |
| Canada | 2 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 4 |
| Electronic Technology | 3 |
| Finance | 3 |
| Consumer Durables | 2 |
Opérationnelle
| Director/Board Member | 9 |
| Chief Executive Officer | 4 |
| Founder | 4 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ori Choshen | 12 |
| Lior Carmon | 7 |
| Amnon Peled | 3 |
- Bourse
- Insiders
- Dikla Berko-Ashur
- Connexions Sociétés
